MarketCap
Edgewell Personal Care Company EPC
$ 27.63
3.52%
Facebook
X
Telegram
Edgewell Personal Care Company Financial Ratios 2025-2007 | EPC
Brief overview of Edgewell Personal Care Company's valuation and returns
This overview follows the five latest available observations from 2021 through 2025.
Key multiples at the end of the period are P/E 48.32x (median 21.65x), EV/EBITDA 17.29x (median 12.78x), P/S 0.55x (median 0.79x). The multiple basket looks neutral against its history, differing from median levels by roughly 0%.
The inverse P/E implies an earnings yield of 2.1%. This is not a dividend yield, but current earnings relative to market price.
Capital efficiency is characterized by ROE 1.6%, ROA 0.7%, ROCE 6.2%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.
The PEG ratio is 5.08x; investors pay a high price per unit of expected growth.
The time from paying for inputs to receiving cash fell from 165 days to 93.8 days. Cash turnover improved.
Conclusion
Edgewell Personal Care Company's profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios Edgewell Personal Care Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
48.3 | 17.6 | 15.5 | 21.6 | 168.2 | 23.3 | -5.2 | 24.8 | 649.5 | 25.2 | -19.1 | 15.6 | 11.0 | 8.5 | 14.8 | 26.0 | 20.2 | - | - |
P/S |
0.6 | 0.8 | 0.8 | 1.0 | 4.2 | 0.8 | 0.9 | 1.1 | 1.6 | 1.9 | 2.2 | 1.2 | 1.0 | 0.8 | 0.8 | - | - | - | - |
EPS |
0.5 | 2.0 | 2.2 | 1.9 | 0.2 | 1.2 | -6.9 | 1.9 | 0.1 | 3.0 | -4.4 | 5.7 | 6.5 | 6.3 | 3.8 | 1.6 | 1.8 | 5.7 | - |
EV (Enterprise Value) |
3.2 B | 3.67 B | 3.76 B | 4.21 B | 3.55 B | 3.32 B | 3.71 B | 4.51 B | 5.65 B | 6.7 B | 7.67 B | 8.83 B | 7.74 B | 7.42 B | 7.97 B | 6.53 B | 6.56 B | -171 M | -363 M |
EBITDA per Share |
3.9 | 5.78 | 6.22 | 5.13 | 6.01 | 4.88 | 7.1 | 7.13 | 7.84 | 7.28 | 4.67 | 13.3 | 14.2 | 13 | 12 | 1.99 | 2.09 | - | - |
EV/EBITDA |
17.3 | 12.8 | 11.8 | 15.5 | 12.3 | 8.0 | 7.3 | 9.2 | 10.6 | 13.0 | 21.6 | 7.8 | 6.3 | 6.1 | 6.8 | 46.9 | 50.3 | -1.2 | - |
PEG |
-24.56 | -10.27 | -40.39 | -3.36 | -84.39 | 5.08 | 0.01 | 0.01 | -6.72 | 0.15 | 0.11 | -1.26 | 2.77 | 0.13 | -0.43 | - | - | - | - |
P/B |
0.8 | 1.1 | 1.2 | 1.5 | 1.2 | 1.1 | 1.5 | 1.5 | 2.1 | 2.5 | 2.8 | 2.2 | 1.8 | 1.7 | 1.8 | 1.4 | 1.4 | - | - |
P/CF |
10.4 | -7.5 | -8.2 | 21.1 | 8.4 | 6.8 | 14.6 | 12.7 | 16.3 | 42.1 | 106.3 | 11.4 | 6.8 | 6.7 | 12.3 | -2870.6 | 5.2 | - | - |
ROE % |
1.64 | 6.22 | 7.45 | 6.78 | 0.72 | 4.72 | -28.55 | 5.92 | 0.33 | 9.77 | -14.77 | 14.12 | 16.59 | 19.76 | 12.43 | 5.26 | 7.13 | 33.05 | - |
ROA % |
0.68 | 2.64 | 3.07 | 2.68 | 0.31 | 1.91 | -10.88 | 2.61 | 0.14 | 3.75 | -5.52 | 5.14 | 6.06 | 6.07 | 3.92 | 1.73 | 2.04 | - | - |
ROCE % |
6.22 | 12.58 | 14.74 | 12.43 | 15.08 | 12.28 | 10.51 | 8.97 | 9.68 | 8.67 | 4.03 | 12.84 | 13.31 | 12.55 | 11.94 | - | - | - | - |
Current Ratio |
1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.7 | 1.6 | 1.3 | 2.3 | 1.7 | 2.5 | 1.7 | 2.2 | 1.9 | 2.1 | 1.5 | 1.4 | - | - |
DSO |
20.3 | 17.5 | 19.7 | 24.2 | 121.9 | 34.1 | 47.3 | 46.0 | 46.2 | 54.3 | 65.5 | 56.5 | 51.2 | 64.9 | 74.8 | - | - | - | - |
DIO |
135.2 | 136.3 | 131.1 | 112.4 | 106.0 | 114.6 | 111.0 | 100.4 | 104.2 | 93.9 | 98.2 | 97.4 | 95.2 | 101.0 | 95.4 | - | - | - | - |
DPO |
61.7 | 58.2 | 58.9 | 61.9 | 62.9 | 69.1 | 69.2 | 72.7 | 69.9 | 59.7 | 69.9 | 62.7 | 52.6 | 48.9 | 42.3 | - | - | - | - |
Operating Cycle |
155.5 | 153.8 | 150.8 | 136.5 | 227.9 | 148.7 | 158.3 | 146.4 | 150.4 | 148.2 | 163.6 | 153.9 | 146.4 | 165.9 | 170.2 | - | - | - | - |
Cash Conversion Cycle |
93.8 | 95.6 | 91.9 | 74.6 | 165.0 | 79.6 | 89.1 | 73.8 | 80.5 | 88.5 | 93.8 | 91.2 | 93.8 | 117.0 | 127.9 | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Edgewell Personal Care Company
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | -1.41 | -1.41 | - | 0.62 | 0.6 | -0.04 | - | 0.99 | 0.72 | 0.1 | - | 1.04 | 0.38 | 0.24 | - | 0.58 | 0.43 | 0.21 | 0.81 | 0.75 | 0.26 | 0.33 | 0.39 | 0.09 | 0.33 | 0.41 | 0.75 | -8.51 | 0.41 | -0.01 | 0.36 | 0.23 | -0.01 | 0.12 | -2.61 | 0.96 | 0.12 | 0.58 | 0.89 | 0.62 | 0.58 | 0.4 | -3.57 | -1.17 | 0.4 | 1.7 | 1.38 | 1.05 | 1.7 | 1.73 | 1.69 | 1.4 | 1.73 | 2.1 | 1.86 | 1.08 | 2.1 | 2.17 | 0.67 | 0.95 | 2.17 | 1.48 |
EBITDA per Share |
1.26 | 0.05 | 0.05 | - | 1.43 | 1.5 | 0.64 | - | 1.93 | 1.68 | 0.97 | - | 1.84 | 1.25 | 1.05 | - | 1.1 | 0.93 | 0.98 | - | 2.12 | 1.26 | 1.17 | 3.69 | 1.62 | 1.17 | 1.1 | 1.28 | 0.86 | 0.41 | 0.41 | 1.35 | 2.89 | 0.41 | 0.45 | 7.11 | 2.86 | 0.45 | 0.41 | 1.16 | 0.75 | 0.41 | 0.34 | 1.51 | 1.04 | 0.34 | 0.54 | 1.57 | 1.05 | 0.54 | 0.53 | 1.76 | 1.19 | 0.53 | 0.62 | 1.84 | 1.23 | - | - | - | - | - | - |
ROE % |
-7.72 | -5.07 | -0.79 | 3.63 | 6.74 | 7.20 | 5.60 | 5.74 | 9.14 | 7.31 | 5.82 | 5.51 | 7.57 | 5.70 | 5.15 | 4.32 | 7.10 | 7.74 | 6.93 | 7.41 | 6.09 | 3.72 | 4.20 | 4.66 | 6.31 | -28.18 | -27.73 | -29.41 | -31.42 | 3.45 | 1.76 | 2.19 | -7.44 | -4.99 | -4.56 | -3.08 | 8.29 | 7.15 | 8.58 | 8.01 | -6.62 | -12.51 | -13.07 | -10.25 | 4.90 | 11.35 | 14.24 | 14.36 | 15.26 | 16.26 | 16.49 | 18.14 | 19.51 | 19.35 | 21.23 | 22.20 | 18.72 | 18.47 | 19.07 | 17.45 | 3.14 | 6.88 | 5.26 |
ROA % |
-3.02 | -1.95 | -0.26 | 1.48 | 2.80 | 2.99 | 2.35 | 2.41 | 3.81 | 3.00 | 2.37 | 2.24 | 2.86 | 1.74 | 2.43 | 2.11 | 2.11 | 3.22 | 2.92 | 3.13 | 2.52 | 1.54 | 1.73 | 1.90 | 2.50 | -11.10 | -10.94 | -11.63 | -12.33 | 1.44 | 0.78 | 0.95 | -3.09 | -2.08 | -1.91 | -1.32 | 3.32 | 2.78 | 3.32 | 3.05 | -2.45 | -4.67 | -4.89 | -3.86 | 1.77 | 4.15 | 5.19 | 5.26 | 5.60 | 5.96 | 6.05 | 6.39 | 6.57 | 6.31 | 6.63 | 6.91 | 5.88 | 5.84 | 6.07 | 5.55 | 1.01 | 2.15 | 1.69 |
ROCE % |
2.15 | 4.77 | 6.66 | 7.93 | 13.18 | 14.27 | 12.07 | 11.45 | 16.98 | 15.48 | 13.10 | 11.41 | 14.78 | 12.01 | 10.31 | 8.18 | 12.88 | 13.56 | 13.64 | 11.59 | 21.00 | 19.26 | 18.05 | 17.96 | 14.69 | 31.13 | 34.98 | 32.22 | 32.22 | 32.22 | 32.22 | 32.22 | 6.13 | - | - | 19.40 | 6.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.7 | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | - | 1.7 | 1.7 | 1.8 | 1.7 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.4 | 1.5 |
DSO |
29.8 | 33.2 | 31.5 | - | 24.1 | 23.5 | 25.3 | - | 20.1 | 18.5 | 20.4 | - | 19.8 | 21.6 | 25.3 | - | 13.4 | 28.2 | 30.1 | 25.2 | 23.9 | 27.9 | 33.0 | 29.6 | 29.9 | 34.6 | 39.1 | 35.5 | 30.8 | 37.1 | 38.9 | 38.5 | 33.3 | 40.9 | 39.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
137.4 | 160.8 | 156.0 | - | 127.3 | 142.5 | 184.1 | - | 120.5 | 136.1 | 158.9 | - | 128.7 | 138.5 | 161.5 | - | 51.1 | 120.2 | 125.7 | - | 106.0 | 112.2 | 115.2 | 35.7 | 109.7 | 120.5 | 126.6 | 37.2 | 102.8 | 126.7 | 120.6 | 33.6 | 94.3 | 117.5 | 115.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
67.0 | 74.3 | 75.4 | - | 56.0 | 59.0 | 79.6 | - | 54.2 | 55.8 | 61.4 | - | 60.0 | 62.8 | 78.7 | - | 26.8 | 63.6 | 71.3 | - | 64.0 | 64.5 | 64.5 | 20.7 | 63.5 | 66.7 | 73.1 | 23.2 | 64.1 | 75.2 | 77.1 | 24.3 | 68.2 | 75.7 | 71.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 187.5 | - | 151.4 | 166.0 | 209.4 | - | 140.6 | 154.6 | 179.3 | - | 148.5 | 160.1 | 186.8 | - | 64.5 | 148.3 | 155.7 | 25.2 | 129.9 | 140.1 | 148.2 | 65.4 | 139.7 | 155.1 | 165.7 | 72.7 | 133.6 | 163.8 | 159.6 | 72.1 | 127.6 | 158.4 | 155.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 112.0 | - | 95.4 | 107.0 | 129.8 | - | 86.4 | 98.9 | 117.9 | - | 88.5 | 97.3 | 108.1 | - | 37.8 | 84.8 | 84.4 | 25.2 | 65.9 | 75.7 | 83.7 | 44.7 | 76.1 | 88.4 | 92.6 | 49.5 | 69.5 | 88.6 | 82.4 | 47.8 | 59.4 | 82.7 | 83.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Edgewell Personal Care Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.81 | 1.58 % | $ 2.28 B |  USA |
 |
United-Guardian
UG
|
$ 7.62 | -1.8 % | $ 35 M | USA |
 |
Unilever PLC
UL
|
$ 60.94 | 1.21 % | $ 133 B |  Britain |
 |
Acme United Corporation
ACU
|
$ 53.94 | 3.97 % | $ 204 M | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.95 | -0.05 % | $ 12.7 M |  China |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
e.l.f. Beauty
ELF
|
$ 77.36 | 1.59 % | $ 4.24 B | USA |
 |
Coty
COTY
|
$ 2.65 | 1.73 % | $ 2.31 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 28.09 | -14.2 % | $ 6.32 B | USA |
 |
Helen of Troy Limited
HELE
|
$ 28.47 | 6.07 % | $ 655 M |  Bermuda |
 |
The Clorox Company
CLX
|
$ 95.55 | 1.87 % | $ 11.8 B | USA |
 |
Church & Dwight Co.
CHD
|
$ 97.64 | 1.52 % | $ 23.7 B | USA |
 |
Newell Brands
NWL
|
$ 5.08 | 0.99 % | $ 2.12 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 109.7 | 2.23 % | $ 36.4 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 20.4 | -0.58 % | $ 367 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 5.08 | - | $ 250 M | USA |
 |
LifeVantage Corporation
LFVN
|
$ 6.53 | 4.15 % | $ 80 M | USA |
 |
The Estée Lauder Companies
EL
|
$ 80.29 | 0.46 % | $ 28.9 B | USA |
 |
USANA Health Sciences
USNA
|
$ 21.32 | 1.91 % | $ 395 M | USA |
 |
The Procter & Gamble Company
PG
|
$ 147.41 | 1.1 % | $ 346 B | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 4.5 | -3.43 % | $ 8.55 M | USA |
 |
Colgate-Palmolive Company
CL
|
$ 90.75 | 0.74 % | $ 73.4 B | USA |
 |
Inter Parfums
IPAR
|
$ 122.55 | 2.34 % | $ 3.93 B | USA |